GeneDx (WGS) News Today $77.40 +2.10 (+2.79%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period The top five midcap stocks of 2024December 20 at 12:37 PM | fxstreet.comGeneDx (NASDAQ:WGS) Shares Gap Down - Should You Sell?GeneDx (NASDAQ:WGS) Shares Gap Down - What's Next?December 20 at 11:44 AM | marketbeat.comKevin Feeley Sells 3,728 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockDecember 19 at 8:21 AM | insidertrades.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Kevin Feeley Sells 3,728 SharesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 3,728 shares of GeneDx stock in a transaction on Monday, December 16th. The stock was sold at an average price of $76.75, for a total transaction of $286,124.00. Following the transaction, the chief financial officer now owns 28,200 shares in the company, valued at approximately $2,164,350. This trade represents a 11.68 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.December 18 at 7:36 PM | marketbeat.comKatherine Stueland Sells 10,501 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 10,501 shares of the business's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $76.75, for a total value of $805,951.75. Following the completion of the sale, the chief executive officer now owns 71,146 shares of the company's stock, valued at approximately $5,460,455.50. This represents a 12.86 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.December 18 at 7:34 PM | marketbeat.comGeneDx to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 16, 2024 | businesswire.comGeneDx: Possibly Turning A Profit In 2025 (Rating Downgrade)December 16, 2024 | seekingalpha.comFmr LLC Has $2.28 Million Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)Fmr LLC raised its holdings in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 295.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,825 shares of the company's stock after purchasing an additional 40,21December 15, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Trading Up 4.8% - Here's WhyGeneDx (NASDAQ:WGS) Stock Price Up 4.8% - Time to Buy?December 13, 2024 | marketbeat.comInsider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells 1,137 Shares of StockDecember 12, 2024 | insidertrades.comCharles Schwab Investment Management Inc. Buys 110,666 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Charles Schwab Investment Management Inc. lifted its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 304.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 147,034 shares of the company's stockDecember 12, 2024 | marketbeat.comGeneDx Rides Revenue Surge, But Valuation Risks LoomDecember 9, 2024 | seekingalpha.comMetLife Investment Management LLC Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS)MetLife Investment Management LLC bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 7,297 shares of the company's stock, vDecember 9, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Sells 134,287 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Jacobs Levy Equity Management Inc. cut its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 66.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,776 shares of the company's stock afterDecember 8, 2024 | marketbeat.comPoint72 Asset Management L.P. Increases Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)Point72 Asset Management L.P. boosted its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 87.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 293,671 shares of the company's stock after puDecember 7, 2024 | marketbeat.comGeneDx expands access to exome testing for pediatric epilepsy patientsDecember 5, 2024 | markets.businessinsider.comGeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New PartnersDecember 5, 2024 | finance.yahoo.comGeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of "Moderate Buy" from AnalystsGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have issued aDecember 5, 2024 | marketbeat.comKevin Feeley Sells 263 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockDecember 4, 2024 | insidertrades.comHealthcare of Ontario Pension Plan Trust Fund Buys New Position in GeneDx Holdings Corp. (NASDAQ:WGS)Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 177,500 shares of the company's stock, valued at approximaNovember 30, 2024 | marketbeat.comSummit Partners Public Asset Management LLC Buys New Position in GeneDx Holdings Corp. (NASDAQ:WGS)Summit Partners Public Asset Management LLC bought a new stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 172,945 shares of the company's stock, valNovember 29, 2024 | marketbeat.comAlgert Global LLC Buys 52,526 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Algert Global LLC lifted its stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 386.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 66,128 shares of the company's stoNovember 27, 2024 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Kevin Feeley Sells 12,019 SharesNovember 26, 2024 | insidertrades.comConnor Clark & Lunn Investment Management Ltd. Purchases New Shares in GeneDx Holdings Corp. (NASDAQ:WGS)Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 60,005 shares of the company's stock,November 25, 2024 | marketbeat.comPrincipal Financial Group Inc. Takes $604,000 Position in GeneDx Holdings Corp. (NASDAQ:WGS)Principal Financial Group Inc. purchased a new stake in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 14,240 shares of the company's stock, valued at approNovember 24, 2024 | marketbeat.comGSA Capital Partners LLP Invests $322,000 in GeneDx Holdings Corp. (NASDAQ:WGS)GSA Capital Partners LLP acquired a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 7,577 shares of the company's stock, valued at approximately $322,000. Other hedge fundNovember 23, 2024 | marketbeat.comGeneDx to Participate in Upcoming Investor ConferenceNovember 22, 2024 | businesswire.comInsider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) Director Sells 31,510 Shares of StockNovember 22, 2024 | insidertrades.comKatherine Stueland Sells 22,307 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockNovember 21, 2024 | insidertrades.comThompson Davis & CO. Inc. Sells 7,244 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Thompson Davis & CO. Inc. cut its stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 33.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,600 shares of the company's stock after selling 7,244 sharesNovember 20, 2024 | marketbeat.comSchool Of Medicine At Mo Icahn Sells 20,359 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockNovember 20, 2024 | insidertrades.comKatherine Stueland Sells 22,307 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 22,307 shares of the firm's stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $70.34, for a total transaction of $1,569,074.38. Following the completion of the transaction, the chief executive officer now directly owns 60,011 shares in the company, valued at approximately $4,221,173.74. The trade was a 27.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.November 20, 2024 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $1,628,651.84 in StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 23,108 shares of the company's stock in a transaction on Friday, November 15th. The shares were sold at an average price of $70.48, for a total transaction of $1,628,651.84. Following the sale, the chief executive officer now owns 82,318 shares of the company's stock, valued at $5,801,772.64. The trade was a 21.92 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.November 20, 2024 | marketbeat.comRoyce & Associates LP Acquires New Shares in GeneDx Holdings Corp. (NASDAQ:WGS)Royce & Associates LP bought a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 28,293 shares of the company's stock, valued at approximately $1,201,0November 20, 2024 | marketbeat.comGeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx DiscoverNovember 19, 2024 | stockhouse.comGeneDx appoints Heidi Chen as chief legal officerNovember 19, 2024 | markets.businessinsider.comGeneDx (NASDAQ:WGS) Shares Gap Down - Here's What HappenedGeneDx (NASDAQ:WGS) Shares Gap Down - Here's WhyNovember 18, 2024 | marketbeat.comGeneDx Announces Heidi Chen as Chief Legal Officer and Corporate SecretaryNovember 18, 2024 | businesswire.comMeet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a YearNovember 16, 2024 | fool.com40,573 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Chartwell Investment Partners LLCChartwell Investment Partners LLC acquired a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 40,573 shares of the company's stock, valued at approximately $1,722,000. Chartwell InvNovember 13, 2024 | marketbeat.com36,615 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Lisanti Capital Growth LLCLisanti Capital Growth LLC acquired a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 36,615 shares of the company's stock, valued at approximately $1,554,00November 11, 2024 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Recommendation of "Moderate Buy" from BrokeragesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six ratings firms that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and three have issued a buy recomNovember 10, 2024 | marketbeat.comNew GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic YieldsNovember 7, 2024 | businesswire.comGeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $64,935,000.00 in StockNovember 5, 2024 | insidertrades.comInsider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells 865,800 Shares of StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) major shareholder School Of Medicine At Mo Icahn sold 865,800 shares of the firm's stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $75.00, for a total transaction of $64,935,000.00. Following the transaction, the insider now directly owns 2,866,833 shares of the company's stock, valued at approximately $215,012,475. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.November 4, 2024 | marketbeat.comGeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual MeetingNovember 4, 2024 | businesswire.comGeneDx 865K share Block Trade; price range $77.00-$80.00November 2, 2024 | markets.businessinsider.comGeneDx 865K share Block Trade priced at $77.00November 1, 2024 | markets.businessinsider.comGeneDx (NASDAQ:WGS) Releases Quarterly Earnings Results, Beats Expectations By $0.25 EPSGeneDx (NASDAQ:WGS - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.25. The firm had revenue of $76.90 million for the quarter, compared to the consensus estimate of $64.98 million. GeneDx had a negative net margin of 31.25% and a negative return on equity of 13.35%. The business's revenue for the quarter was up 44.3% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.82) EPS.November 1, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Gap Down After Insider SellingGeneDx (NASDAQ:WGS) Shares Gap Down Following Insider SellingNovember 1, 2024 | marketbeat.com Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now WGS Media Mentions By Week WGS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WGS News Sentiment▼0.510.60▲Average Medical News Sentiment WGS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WGS Articles This Week▼104▲WGS Articles Average Week Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HIMS News Today GH News Today OPCH News Today SHC News Today VCYT News Today BTSG News Today LFST News Today SGRY News Today CON News Today PRVA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WGS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WGS Stock Alerts